Ouvrages publiés en collaboration (1)
  1. 1. Deconinck, N., & Goemans, N. (2019). Neuromuscular Disorders in Children: A Multidisciplinary Approach to Management.
    2.   Parties d'ouvrages collectifs (4)
  2. 1. Deconinck, N., & Al Husni Al Keilani, M. (2014). Comprehensive guide to Autism: Rett syndrome and sleep. In V. B. Patel, V. Preedy, & C. R. Martin (Eds.), Comprehensive guide to Autism: Section XVIII. Rett syndrome (1 ed., pp. 256-289). New York: Springer-Verlag.
  3. 2. Deconinck, N., Soncarrieu, M.-V., & Dan, B. (2012). Toward better recognition of early predictors for autism spectrum disorders (ASDS). In Pediatric Neurology (pp. 65-90). Nova Science Publishers, Inc.
  4. 3. Deconinck, N., Soncarrieu, M., & Dan, B. (2012). Pediatric Neurology: Recent advances in early neuroanatomic and clinical features of Autism. In Pediatric Neurology (pp. 125-137). edited by NOVA publications.
  5. 4. Deconinck, N., & Gillis, J. M. (1998). Mechanisms of Work Production and Work Absorption in Muscle: The physiological evaluation of gene therapies of dystrophin-deficient muscles. In Mechanisms of Work Production and Work Absorption in Muscle. New York: Edited by Sugi and Pollack.
    6.   Articles dans des revues avec comité de lecture (84)
  6. 1. Neuens, S., Soblet, J., Penninckx, A., Detry, C., Badoer, C., Desmyter, L., Peyrassol, X., Wilkin, F., Busson, A., Bruneau, M., Grenet, M.-L., Le Morillon, A., Aeby, A., Deconinck, N., Prigogine, C., Monier, A., Juvené, E., Balfroid, T., Van Hecke, A., Christiaens, F., Depondt, C., Brachet, C., Delvenne, V., Lufin, N., Bouysran, Y., Kammoun, M., Daneels, D., Caljon, B., Croes, D., Olsen, C., Van Dooren, S., Migeotte, I., Vandernoot, I., Marangoni, M., Coppens, S., Smits, G., & Vilain, C. (2025). Diagnostic yield of clinical exome sequencing in 868 children with neurodevelopmental disorders. European journal of medical genetics, 105030. doi:10.1016/j.ejmg.2025.105030
  7. 2. Henzi, B. C., Putananickal, N., Schmidt, S., Nagy, S., Rubino–Nacht, D., Schaedelin, S., Amthor, H., Childs, A. –., Deconinck, N., Horrocks, I., Houwen–van Opstal, S., Laugel, V., Lobato, M. L., Osorio, A. N., Schara–Schmidt, U., Spinty, S., von Moers, A., Lawrence, F., Hafner, P., Dorchies, O. O., & Fischer, D. (2025). Safety and efficacy of tamoxifen in non-ambulant patients with Duchenne muscular dystrophy: a multicentre, randomised, double–blind, placebo–controlled, phase 3 trial (TAMDMD Group B). Neuromuscular disorders, 47, 105275. doi:10.1016/j.nmd.2025.105275
  8. 3. Ruiz Chicaiza, P., Kaleeta Maalu, J.-P., Chéron, G., Cebolla Alvarez, A. M., & Deconinck, N. (2024). Gait analysis in children with Duchenne Muscular Dystrophy: Overground vs. Treadmill walking. Gait & posture, 113, 196-197. doi:10.1016/j.gaitpost.2024.07.211
  9. 4. Akodad, S., Desmedt, D., Baijot, S., Stevens, H., & Deconinck, N. (2024). Cognition and communication in patients with spinal muscular atrophy: A systematic review. Heliyon, 10(e33677).
  10. 5. McDonald, C. C., Signorovitch, J., Mercuri, E. M. E., Niks, E. E., Wong, B. B., Fillbrunn, M., Sajeev, G., Yim, E., Dieye, I., Miller, D., Ward, S. S., Goemans, N., Deconinck, N., Tulinius, M., de Groot, I., Flanigan, K., de Resende, M. B. D., Vita, G., Schara, U., Kirschner, J., Topaloglu, H., Monges, S., & Cances, C. (2024). Functional trajectories before and after loss of ambulation in Duchenne muscular dystrophy and implications for clinical trials. PloS one, 19(6 June), e0304099. doi:10.1371/journal.pone.0304099
  11. 6. Lilien, C., Vrscaj, E., Thapaliya, G., Deconinck, N., De Waele, L., Duong, T., Haberlová, J., Kumhera, M., Peirens, G., Szabo, L., Tahon, V., Tang, W. W., Benmhammed, N., Médard, L., & Servais, L. (2024). Patients’ Perceptions of Nusinersen Effects According to Their Responder Status. Journal of Clinical Medicine, 13(12), 3418. doi:10.3390/jcm13123418
  12. 7. Oskoui, M., Day, J. W., Deconinck, N., Mazzone, E. S., Nascimento, A., Saito, K., Vuillerot, C., Baranello, G., Goemans, N., Kirschner, J., Kostera-Pruszczyk, A., Servais, L., Papp, G., Gorni, K., Kletzl, H., Martin, C., McIver, T., Scalco, R. S., Staunton, H., Yeung, W. Y., Fontoura, P., & Mercuri, E. (2023). Two-year efficacy and safety of risdiplam in patients with type 2 or non-ambulant type 3 spinal muscular atrophy (SMA). Journal of neurology, 270(5), 2531-2546. doi:10.1007/s00415-023-11658-6
    13. << Précédent 1 2 3 4 5 6 7 8 9 10 Suivant >>